ライフサイエンスコーパス: fatality

1 th and indication for liver transplantation (fatality).

2 g themselves in harm's way (e.g., accidental fatalities).

3 eating bacteria is associated with high case fatality.

4 a primary, a contributory, or no role in the fatality.

5 The outcome was 60-day case fatality.

6 e cognitive deficit and an increased risk of fatality.

7 ratio of 5.2 (95% CI 2.0-13.5) and 11% case fatality.

8 hypervirulent GAS strain that resulted in a fatality.

9 ose that differentiate patient survival from fatality.

10 almonella disease, associated with high case fatality.

11 fy an immune signature that is unique in EVD fatalities.

12 outbreak in India has reportedly led to 800 fatalities.

13 nza A(H7N9) have been reported including 122 fatalities.

14 ancer is the leading cause of cancer-related fatalities.

15 nfected at least 1,082 people, including 439 fatalities.

16 d help discriminate long-term survivors from fatalities.

17 VD) led to more than 27,000 cases and 11,000 fatalities.

18 role cases, malignancies accounted for most fatalities.

19 enia were independently associated with DILI fatalities.

20 ve the highest risk for food allergy-related fatalities.

21 a prelude to rising incidence of malaria and fatalities.

22 disease outbreak to 20 reported cases and 8 fatalities.

23 Es may lead to prolonged hospitalizations or fatalities.

24 higher positive predictive value for overall fatality (14% versus 10%) and a stronger independent ass

25 Treated cases of EOD had very high case fatality (17/36, 47%), especially within 24 h of birth,

26 ality was 20.3%; Salmonella Enteritidis case fatality (27.8%) was higher than for other serovars (P =

27 were adult males (68%), but the highest case fatality (39%) was seen in children aged younger than 5

28 te a prognostic model to predict 60-day case fatality after aneurysmal subarachnoid hemorrhage develo

29 In contrast, case-fatality after complications was more than threefold hig

30 gland and Wales (1992-2012) and crosschecked fatalities against a prospective fatal anaphylaxis regis

31 nnatural cause of death represented 40.6% of fatalities among women with postpartum psychiatric disor

32 atal and nonfatal CHD incidence and CHD case-fatality among blacks and whites in the Atherosclerosis

33 fully understood, and future projections of fatalities and losses available today are based on simpl

34 With MERS outbreaks resulting in over 35% fatalities and now spread to 27 countries, MERS-CoV pose

35 more important, insofar as they can prevent fatalities and promote other pragmatic benefits.

36 The crude case fatality and adjusted hazard ratio (HR) were highest wit

37 Case fatality and hospitalization rates for US patients with

38 as a cause of encephalitis with high rate of fatality, and should notify public health departments an

39 013 strain in the Netherlands, its high case fatality, and the availability of a safe and effective v

40 orate disease or reduce disease severity and fatalities are still needed to reduce the burden of deng

41 men, and whether associations differ by case fatality are unclear.

42 r 217 countries and territories using a case-fatality-based approach.

43 intenance phases, but most were mild with no fatalities being reported.

44 ile discriminated only between survivors and fatalities but not mouse or pneumococcal strains used du

45 acteremia has been associated with high case fatality, but it remains unknown to what extent death is

46 ocument trends in anaphylaxis admissions and fatalities by age, sex, and cause in England and Wales o

47 enerally, but neurological sequelae and even fatalities can occur, especially in severe forms that mi

48 atabases that record hospital admissions and fatalities caused by anaphylaxis in England and Wales (1

49 CC (n = 441) was associated with higher case fatality compared to 3-factor PCC (n = 144, HR = 1.441,

50 syncytial viral" combined with "mortality", "fatality", "death", "died", "deaths", or "CFR" for artic

51 ber of law-enforcement-related deaths (i.e., fatalities due to injuries inflicted by law enforcement

52 adverse events were reported, including one fatality due to worsening pre-existing peripheral arteri

53 nfluenza virus caused an estimated 2 million fatalities during the pandemic.

54 e or specific to drunk-driving fatalities or fatalities during weekends and holidays.

55 public health threat, with more than 55,000 fatalities each year around the world.

56 platforms that differentiated survivors and fatalities early after infection.

57 The large numbers of estimated cases and fatalities emphasise that the disease warrants renewed a

58 The large numbers of estimated cases and fatalities emphasize that the disease warrants renewed a

59 a leading cause of fungal-infection-related fatalities, especially in immunocompromised hosts.

60 serious global infectious disease with high fatality, especially in developing nations.

61 ed the association of risk factors with case fatality for children younger than 2 months, 2-11 months

62 Case fatality for early-onset NTHi was 19% (21/110); each add

63 lict fatalities (mean +/- SD: 1.41 +/- 10.21 fatalities) for children living in rural areas during th

64 ed the data on meningitis incidence and case fatality from countries reporting to the network.

65 Case fatality from these diseases remains high and treatment

66 was unprecedented in the number of cases and fatalities, geographic distribution, and number of natio

67 A lack of autopsy studies from MERS fatalities has hindered understanding of MERS-CoV pathog

68 Alarmingly, a large number of fatalities have been linked to overdose of fentanyl deri

69 Rare fatalities have been reported in extracutaneous manifest

70 Road traffic injuries and fatalities have increased alongside increased use of mot

71 Reports of race-related triathlon fatalities have raised questions regarding athlete safet

72 bacteremia is associated with increased case fatality; however, the mortality attributable to these i

73 r thousands of clinical cases and associated fatalities in China, Japan, and South Korea.

74 There were 283 183 MVC fatalities in occupants aged 10 years or older from 2001

75 d, and weekend- and holiday-specific traffic fatalities in the 100 most populated metropolitan areas

76 iovascular diseases are the leading cause of fatalities in the United States.

77 Investigations of (LP)H7N1-associated fatalities in wild birds and quarantined exotic birds in

78 DILI leads directly or indirectly to fatality in 7.6% of cases; 40% of these had nonacute liv

79 evel estimates of sepsis incidence rates and fatality in adult populations using consensus criteria a

80 PCC might be associated with the lowest case fatality in reversal of VKA-ICH, and FFP may be equivale

81 The case fatality in the elevated group was 100% compared to 17%

82 Case fatality in the west African Ebola virus disease epidemi

83 is a serious complication, but had low case fatality in trials of aspirin and is not generally thoug

84 antihypertensive medication treatment, case fatality, incidence and prevalence, and cardiovascular d

85 The role of DILI in these fatalities is poorly characterized, particularly when fa

86 ed pneumonia cases and deaths; however, case fatality is substantial.

87 ave brought waves of increased morbidity and fatality, leading it to become a serious public health p

88 Exposure to 5 localized civil conflict fatalities (mean +/- SD: 1.41 +/- 10.21 fatalities) for

89 Fertilizer Company (WFC) that resulted in 15 fatalities, more than 260 injuries, and damage to more t

90 Three neonic poisoning studies reported two fatalities (n = 1,280 cases) and an occupational exposur

91 Three neonic poisoning studies reported two fatalities (n = 1,280 cases) and an occupational exposur

92 s is poorly characterized, particularly when fatalities occur >26 weeks after DILI onset.

93 ly, but the most severe cases and almost all fatalities occur in infants too young to be vaccinated.

94 supportive measures and systemic steroids, 2 fatalities occurred and were attributed to treatment-eme

95 Among 1,089 patients, 107 (9.8%) fatalities occurred within 2 years.

96 Most clinical cases and fatalities of babesiosis are caused by Babesia microti C

97 Here, we describe the fatality of an immunocompromised patient who received th

98 The fatality of avian influenza A(H7N9) infection in humans

99 us rehydration therapy have reduced the case fatality of cholera from more than 50% to much less than

100 tality in Africa, but the incidence and case fatality of each disease vary markedly by region.

101 ed in aggregate or specific to drunk-driving fatalities or fatalities during weekends and holidays.

102 n, risk of bleeding on anticoagulation, case fatality or all-cause mortality, and other important con

103 her this cytokine storm is the main cause of fatality or is a consequence of extensive virus replicat

104 N6 viruses from this clade have caused three fatalities out of six severe human infections in China s

105 Case-fatality proportion (CFP) was higher among countries wit

106 everity was assessed with four markers: case-fatality rate (1.3%), length of ICU stay (mean, 3.0 +/-

107 e D having the highest 30-day estimated case-fatality rate (19% vs 3%-14%).

108 pneumonia, mechanical ventilation and higher fatality rate (28.6%) than other types, particularly HAd

109 The EOD case fatality rate (71%) was higher than in LOD (32%) or cont

110 Case-fatality rate (8%) and development of sequelae (29%) was

111 V infection outbreak in history, with a case-fatality rate (90%) similar to that for Zaire ebolavirus

112 s 9.9% [964 of 9755]; P < .001) and the case fatality rate ([CFR] 13.7 [469 of 3429] vs 7.6 [1344 of

113 ependently associated with an increased case fatality rate (adjusted subdistribution hazard ratio [SH

114 c areas are continuing to grow, but the case fatality rate (CFR) has steadily decreased.

115 s, a life-threating disease with a high case fatality rate despite treatment with antibiotics.

116 The case-fatality rate differed significantly between subclades (

117 Morbidity and case-fatality rate due to PM remain substantial.

118 Based on our model, case fatality rate estimates by subregion ranged from 0.7 (ce

119 The overall in-hospital case-fatality rate for patients who developed cardiogenic sho

120 on for relevant age and sex groups) and case-fatality rate for primary acute myocardial infarction di

121 hen calculated the size-specific cancer case fatality rate for two time periods: a baseline period be

122 us causes hemorrhagic fever with a high case fatality rate for which there is no approved therapy.

123 The absolute fatality rate from GI bleeding was low and similar in bo

124 However, case fatality rate in 2012 remained high for children with ve

125 The case-fatality rate in HEU infants (29% [74/253]) was intermed

126 highest bacterial meningitis attack and case fatality rate in the world.

127 non as well as the contributors to high case-fatality rate is a growing public health concern to enab

128 The case fatality rate of 1182 patients with laboratory-confirmed

129 morrhagic manifestations and an initial case fatality rate of 12 to 30% was reported.

130 fection is cerebral malaria (CM) with a case fatality rate of 15-25% in African children despite effe

131 d in Jiangsu and Anhui provinces with a case fatality rate of 16.1%.

132 ed risk of poor outcome (25%-50% risk): Case Fatality Rate of 21% in the placebo group and 52% in the

133 uated, 21 died, representing an overall case fatality rate of 30%.

134 a coronavirus, is highly lethal, with a case fatality rate of 35 to 40%.

135 n 1,791 cases of MERS and 640 deaths (a case fatality rate of 36%).

136 Previous studies describe a case-fatality rate of 5%-15% and up to 20% of survivors suffe

137 of whom died, and calculated an overall case fatality rate of 6.6% (95% CI 6.4-6.7).

138 some hemorrhagic manifestations with a case fatality rate of about 2 to 15%.

139 iopulmonary syndrome (HCPS) in Chile, with a fatality rate of about 35%.

140 n the United States, and carries the highest fatality rate of any food-borne pathogen.

141 nfirmed cases of SARS and 774 deaths (a case fatality rate of approximately 10%).

142 agent of a severe respiratory disease with a fatality rate of approximately 30%.

143 ymptoms and multi-organ failure, with a case fatality rate of approximately 36%.

144 ated with the higher severity of illness and fatality rate of HAdV-7.

145 rbidity, age, epidemic period and sex on the fatality rate of MERS cases and its variation across cou

146 The crude fatality rate of MERS cases was 32.1% (95% credibility i

147 iratory syndrome (MERS), and an initial case fatality rate of more than 40%.

148 l infarction had two to three times the case-fatality rate of patients in whom acute myocardial infar

149 vere hemorrhagic fever in humans with a case-fatality rate ranging from 25 to 36%.

150 s that are mild or subclinical, and the case-fatality rate remain largely unanswered.

151 The case fatality rate significantly decreased between 2001 (15.2

152 r 450 documented human infections with a 30% fatality rate since early 2013.

153 umors, the decline in the size-specific case fatality rate suggests that improved treatment was respo

154 ad in South Africa and carries a higher case fatality rate than previously appreciated.

155 at convalescent transfusions reduce the case-fatality rate to 12.5% (range, 7.5%-17.5%), we projected

156 s to primary septicaemia have a similar case fatality rate to category BSL 3 and 4 pathogens, such as

157 In 2001, the mean fatality rate was 14.6 per 100 000 persons, 16 states ha

158 The overall case fatality rate was 29.2%, which declined from 35.4% in 20

159 Case fatality rate was 3.1%.

160 The observed 60-day case fatality rate was 30.6%.

161 Case fatality rate was 37% (55/150).

162 The overall case-fatality rate was 40%.

163 The overall case fatality rate was 57%.

164 In 2010, the mean fatality rate was 9.7 per 100 000 persons, 30 states had

165 In this outbreak the case fatality rate was about 67%.

166 analyses indicated that the decrease in case fatality rate was consistent across most subgroups.

167 ompared to immunocompetent persons; the case fatality rate was elevated in both younger (odds ratio [

168 The case fatality rate was estimated at 74.4% (95% CI, 68.3, 79.8

169 interquartile range, 18-40), the 2-year case fatality rate was high (500 deaths, 16.9%).

170 The overall case-fatality rate was higher among patients with XDR P. aeru

171 devastating condition with an estimated 60% fatality rate without treatment.

172 ses per 100,000 persons with 56 deaths (case fatality rate, 10.7%).

173 000 persons per year) with 1116 deaths (case-fatality rate, 11.7%).

174 -confirmed MERS-CoV infection, 93 died (case fatality rate, 36.5%).

175 6 IPD cases and 150 IPD-related deaths (case fatality rate, 4.8%).

176 overage of antimalarial drug treatment, case fatality rate, and population distribution according to

177 oV) infection is associated with a high case-fatality rate, and the potential pandemic spread of the

178 lected by using perfusion CT, including case-fatality rate, favorable outcome (modified Rankin Scale

179 ed worldwide and associated with a high case fatality rate, reinforcing the need for strongly coordin

180 urring throughout Saudi Arabia at a 38% case fatality rate, with the potential for worldwide spread v

181 pitals probably contributed to the high case-fatality rate.

182 ed cases have been reported, with a 53% case-fatality rate.

183 e onset in the population, and the high case fatality rate.

184 ) is a preventable pneumonia with a 30% case fatality rate.

185 r (CCHF) is a severe viral disease with high fatality rate.

186 neuroinvasive disease with up to a 10% case fatality rate.

187 tal zoonotic disease with a nearly 100% case fatality rate.

188 auses viral hemorrhagic fever and has a high fatality rate.

189 mans, whereas H5N1 avian influenza has a 60% fatality rate.

190 ing a severe hemorrhagic disease with a high fatality rate.

191 een reported to date, with approximately 36% fatality rate.

192 y illness and is associated with a high case fatality rate; however, the pathogenesis of severe and f

193 R), with a "low severity" scenario with case fatality rates (CFR) of 0.05%-0.1%, or a "high severity"

194 neffective antimicrobials may result in case fatality rates (CFRs) exceeding 70%(4,5).

195 on during hospital stay and their associated fatality rates (during or within 28 days of being in hos

196 legislation correlated with firearm-related fatality rates (FFR) during a 15-year period.

197 Gastrointestinal bleeding incidence and case-fatality rates account only for age and sex.

198 n were found to have a significant impact on fatality rates after taking into account the age and com

199 Case fatality rates among African children with cerebral mala

200 Case fatality rates among hospitalized patients diagnosed wit

201 isk-adjusted complication incidence and case-fatality rates among patients experiencing serious compl

202 and MERS betacoronaviruses, which have high fatality rates and pandemic potential.

203 iated coronavirus (MERS-CoV) cause high case fatality rates and remain major human public health thre

204 Case fatality rates are estimated to be in the 30% range, and

205 Cardiovascular disease (CVD) fatality rates are higher for women than for men, yet ob

206 hy, and increased post-myocardial infarction fatality rates are increasingly understood in mechanisti

207 We then created collective surgical case fatality rates by WHO region.

208 The in-hospital fatality rates decreased from 65% to 50% for ACLF and fr

209 in humans and other primates, with high case fatality rates during human outbreaks.

210 thal hemorrhagic fever in primates with high fatality rates during outbreaks and EBOV may be exploite

211 al precludes adequate assessment of why case-fatality rates fell.

212 We examined trends in case fatality rates for all-cause clinical pneumonia and its

213 We validated our model against known case fatality rates for caesarean delivery.

214 Admission and fatality rates for drug- and insect sting-induced anaphy

215 001-2011) in the incidence and hospital case-fatality rates for patients who developed cardiogenic sh

216 The case-fatality rates for septic shock, STSS, and NF were 45%,

217 the disease is treatable, reported RMSF case fatality rates from this region are high (7%) compared t

218 High fatality rates have led to an increased urgency to bette

219 auses a severe respiratory disease with high fatality rates in human patients.

220 are important infectious diseases with high fatality rates in members of the Felidae family.

221 Case fatality rates in west Africa were initially greater tha

222 sed outbreaks in human populations with case-fatality rates of approximately 36%.

223 ted hantavirus pulmonary syndrome, with case fatality rates of around 40%.

224 ry trends in the incidence and hospital case-fatality rates of cardiogenic shock in patients hospital

225 Fatality rates of infectious diseases are often higher i

226 mans and nonhuman primates (NHPs), with case-fatality rates ranging from 23% to 90%.

227 isease in humans is highly lethal, with case fatality rates ranging from 25 to 90%.

228 nd encephalitis in Southeast Asia, with case fatality rates ranging from 40% to more than 90%.

229 African American women also have case fatality rates related to preeclampsia 3 times higher th

230 15% over the time period studied, but annual fatality rates remained stable at 0.047 cases (95% CI, 0

231 es with primary seat belt laws had lower MVC fatality rates than states with secondary laws (adjusted

232 ), causes lethal hemorrhagic fever with case fatality rates that have exceeded 50% in some outbreaks.

233 ments in hospital care may have reduced case fatality rates though a lack of sufficient data on quali

234 avivirus disease, and early detection lowers fatality rates to below 1%.

235 r dengue disease, and early detection lowers fatality rates to below 1%.

236 ria pseudomallei and is associated with case-fatality rates up to 40%.

237 s a hemorrhagic fever virus that causes high fatality rates when it spreads from zoonotic vectors int

238 tes, baseline GI bleeding incidence and case-fatality rates, and disutilities associated with aspirin

239 s that can cause hemorrhagic fever with high fatality rates, and there are no approved vaccines or th

240 th calibrated parameters for infection, case fatality rates, and vaccine efficacy, basic childhood va

241 mpanied by changes in LASV genome abundance, fatality rates, codon adaptation, and translational effi

242 infections, including 7-day and 30-day case-fatality rates, in Finland during 2004-2014 and linked t

243 hat causes sporadic outbreaks with high case fatality rates.

244 f invasive disease with high associated case-fatality rates.

245 ) can cause hemorrhagic fever with high case fatality rates.

246 uman viral hemorrhagic fevers with high case fatality rates.

247 use serious disease outbreaks with high case fatality rates.

248 y is likely to reduce historically high case fatality rates.

249 are known to cause infections with high case fatality rates.

250 reas has often been accompanied by high case-fatality rates.

251 a severe hemorrhagic disease with high case fatality rates; there are no approved vaccines or therap

252 The case fatality ratio (CFR) of Ebola virus disease (EVD) can va

253 The overall in-hospital case fatality ratio among the cases was 4.8% (2/42), both dea

254 solidation was associated with a higher case fatality ratio at 30-day follow-up (13.5%) compared to o

255 The case fatality ratio for HWs and non-HWs with EVD was 69% and

256 US surveillance data suggest that the case fatality ratio is substantially higher in children with

257 The case fatality ratio of pertussis-infected pneumonia cases 1-5

258 ficantly (P < .0001) over time, but the case fatality ratio remained constant at approximately 10%.

259 had tuberculosis treatment, the pooled case fatality ratio was 0.9% (95% CI 0.5-1.6).

260 es in the pre-treatment era, the pooled case fatality ratio was 21.9% (95% CI 18.1-26.4) overall.

261 fection, malaria, and malnutrition; the case fatality ratio was 22.1% (71/321) in children aged <5 ye

262 The case-fatality ratio was high in patients aged <5 years (80%)

263 The pooled case fatality ratio was significantly higher in children aged

264 incidence of iNTS, its high associated case fatality ratio, and the common detection of multidrug-re

265 analysis to produce pooled estimates of case fatality ratios from the included studies, which we divi

266 Case fatality ratios in children with tuberculosis are poorly

267 italization ratios of 0.5% or 4.2%, and case fatality ratios of 0.08% or 0.53%.

268 With few exceptions, case-fatality ratios were fairly consistent, ranging between

269 ALRI mortality by combining in-hospital case fatality ratios with hospital admission estimates from h

270 High case-fatality ratios, substantial disease-related morbidity,

271 ematic review evidence on corresponding case-fatality ratios.

272 Ebola incidence and case-fatality records from 2014 Liberian Ministry of Health a

273 pathologic findings of 46 consecutive infant fatalities referred from the state medical examiner's of

274 contemporary estimates of the likelihood of fatality resulting from an ICD shock while driving, shou

275 dom-effects meta-analyses of incidence, case fatality risk (CFR), and serotype prevalence.

276 ore immediate measure is the hospitalization fatality risk (HFR), defined as the probability of death

277 from December to March, and the overall case-fatality risk was 483 (53.5%) of 903 cases which varied

278 The case fatality risk was widely used to assess severity, but an

279 there were no significant differences in the fatality risk, history of exposure to poultry, history o

280 , first recognized in 2012, with a high case fatality risk, no vaccine, and no treatment beyond suppo

281 mate non-fatal anaphylaxis risk or all-cause fatality risk.

282 ica is unprecedented, causing more cases and fatalities than all previous outbreaks combined, and has

283 rimary seat belt laws had lower rates of MVC fatalities than those with secondary laws.

284 unk driving and the 10,000 resulting traffic fatalities that occur annually in the United States.

285 , we present projections of flood losses and fatalities under 100 individual scenario and model combi

286 analysis, we compared all-cause 30-day case fatality using Cox regression.

287 ure, 448 (81.0%) were aged <5 years and case fatality was 20.3%; Salmonella Enteritidis case fatality

288 Case-fatality was 9%; 3/630 (0.5%) children discharged testin

289 CHD case fatality was higher among black versus white men and wom

290 Case fatality was higher in children aged less than 2 years (

291 Case fatality was lowest (5.9%) during this year.

292 However, for patients with CRBSI, case fatality was similar for infections caused by enterococc

293 Only fatalities were analyzed from the database, and the degr

294 VIT proved to be safe and no fatalities were recorded in the studies included in this

295 Disease incidence and case fatality were measured in immunocompromised populations

296 tal and non-fatal anaphylaxis, and all-cause fatalities, were measured using a risk ladder.

297 iation with the number of subsequent traffic fatalities, whether measured in aggregate or specific to

298 Our aim was to compare case fatality with different reversal strategies.

299 a stronger independent association with DILI fatalities within 26 weeks compared to the original vers

300 nd 100 mg/kg resulted in posterior means for fatality without graft failure of 0.7% (credible interva